JP2021522783A5 - - Google Patents
Info
- Publication number
- JP2021522783A5 JP2021522783A5 JP2020560827A JP2020560827A JP2021522783A5 JP 2021522783 A5 JP2021522783 A5 JP 2021522783A5 JP 2020560827 A JP2020560827 A JP 2020560827A JP 2020560827 A JP2020560827 A JP 2020560827A JP 2021522783 A5 JP2021522783 A5 JP 2021522783A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- protein
- nonviral
- abp
- aptamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024093050A JP7832700B2 (ja) | 2018-05-01 | 2024-06-07 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
| JP2026031877A JP2026083211A (ja) | 2018-05-01 | 2026-02-27 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862665080P | 2018-05-01 | 2018-05-01 | |
| US62/665,080 | 2018-05-01 | ||
| PCT/US2019/030198 WO2019213257A1 (en) | 2018-05-01 | 2019-05-01 | Lentiviral-based vectors and related systems and methods for eukaryotic gene editing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024093050A Division JP7832700B2 (ja) | 2018-05-01 | 2024-06-07 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522783A JP2021522783A (ja) | 2021-09-02 |
| JP2021522783A5 true JP2021522783A5 (cg-RX-API-DMAC7.html) | 2022-04-01 |
| JP7506405B2 JP7506405B2 (ja) | 2024-06-26 |
Family
ID=66676890
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560827A Active JP7506405B2 (ja) | 2018-05-01 | 2019-05-01 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
| JP2024093050A Active JP7832700B2 (ja) | 2018-05-01 | 2024-06-07 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
| JP2026031877A Pending JP2026083211A (ja) | 2018-05-01 | 2026-02-27 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024093050A Active JP7832700B2 (ja) | 2018-05-01 | 2024-06-07 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
| JP2026031877A Pending JP2026083211A (ja) | 2018-05-01 | 2026-02-27 | 真核生物の遺伝子編集のためのレンチウイルスベースのベクターならびに関連システムおよび方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12398182B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3788155A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7506405B2 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019262029B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3098137A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019213257A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| WO2019213257A1 (en) | 2018-05-01 | 2019-11-07 | Wake Forest University Health Sciences | Lentiviral-based vectors and related systems and methods for eukaryotic gene editing |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| US20210403907A1 (en) | 2018-09-18 | 2021-12-30 | Vnv Newco Inc. | Arc-based capsids and uses thereof |
| EP3852813A4 (en) * | 2018-09-18 | 2022-06-22 | VNV Newco Inc. | ARC-BASED CAPSIDS AND THEIR USES |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| CN110819707B (zh) * | 2019-11-24 | 2023-07-18 | 中南大学湘雅医院 | 一种针对多种来源细胞样本中内部核糖体结合位点元件的高通量鉴定方法 |
| WO2021142343A1 (en) * | 2020-01-09 | 2021-07-15 | The Regents Of The University Of California | Targeting transfer rna for the suppression of nonsense mutations in messenger rna |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| JP2023550381A (ja) * | 2020-11-19 | 2023-12-01 | ウェイク・フォレスト・ユニバーシティ・ヘルス・サイエンシーズ | 真核生物遺伝子編集のためのベクター、システムおよび方法 |
| EP4277647A4 (en) * | 2021-01-12 | 2025-03-19 | University of Massachusetts | Allele-specific inactivation of mutant HTT by gene editing of coding single nucleotide polymorphisms |
| WO2022165262A1 (en) * | 2021-01-28 | 2022-08-04 | The Broad Institute, Inc. | Compositions and methods for delivering cargo to a target cell |
| CA3206732A1 (en) * | 2021-02-12 | 2022-08-18 | Baisong Lu | Engineered extracellular vesicles and their uses |
| WO2022216536A1 (en) * | 2021-04-06 | 2022-10-13 | Animatus Biosciences, Inc. | Selective expression of mrnas in cardiomyocytes without cardiac fibroblast stimulation |
| US20240366790A1 (en) * | 2021-05-21 | 2024-11-07 | Aarhus Universitet | Lentivirus-derived nanoparticles comprising crispr/cas9 ribonucleoprotein complexes |
| JP7125727B1 (ja) | 2021-09-07 | 2022-08-25 | 国立大学法人千葉大学 | 核酸配列改変用組成物および核酸配列の標的部位を改変する方法 |
| AU2023232138A1 (en) * | 2022-03-08 | 2024-09-26 | Wake Forest University Health Sciences | Compositions, systems and methods for eukaryotic gene editing |
| CN116218906A (zh) * | 2023-01-31 | 2023-06-06 | 安可来(重庆)生物医药科技有限公司 | 一种rna编辑器表达质粒、外泌体适配子融合表达质粒以及一种靶向基因rna编辑方法 |
| WO2025242168A1 (en) * | 2024-05-22 | 2025-11-27 | Nanjing Legend Biotech Co., Ltd. | Methods of making cells expressing an engineered receptor |
| CN118903442A (zh) * | 2024-07-19 | 2024-11-08 | 上海佰炼生物医药科技有限公司 | 基于PP7 RNA茎环结构的高效VLP载体及其用于递送mRNA |
| CN119662735A (zh) * | 2024-10-10 | 2025-03-21 | 上海佰炼生物医药科技有限公司 | 一种基于核定位信号和pp7 rna茎环结构的重组质粒及其载体系统和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004225520A1 (en) | 2003-03-25 | 2004-10-14 | Stratagene | DNA polymerase fusions and uses thereof |
| GB0526210D0 (en) * | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Vectors |
| US20120202276A1 (en) | 2010-02-26 | 2012-08-09 | Life Technologies Corporation | Modified Proteins and Methods of Making and Using Same |
| WO2015002956A1 (en) | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Exosome delivery system |
| WO2015089473A1 (en) * | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
| US9580727B1 (en) * | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
| US10624849B2 (en) | 2015-09-28 | 2020-04-21 | Northwestern University | Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites |
| WO2017059902A1 (en) * | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| CN105861485B (zh) * | 2016-04-20 | 2021-08-17 | 上海伊丽萨生物科技有限公司 | 一种提高基因置换效率的方法 |
| AU2017263137B2 (en) * | 2016-05-13 | 2021-05-27 | Flash Therapeutics | Particle for the encapsidation of a genome engineering system |
| KR102678809B1 (ko) | 2017-05-18 | 2024-06-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 표적화된 핵산 편집을 위한 시스템, 방법 및 조성물 |
| CN111328290A (zh) | 2017-06-26 | 2020-06-23 | 博德研究所 | 用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法 |
| WO2019213257A1 (en) | 2018-05-01 | 2019-11-07 | Wake Forest University Health Sciences | Lentiviral-based vectors and related systems and methods for eukaryotic gene editing |
| WO2020163396A1 (en) | 2019-02-04 | 2020-08-13 | The General Hospital Corporation | Adenine dna base editor variants with reduced off-target rna editing |
| AU2020466994B2 (en) | 2019-09-17 | 2026-05-28 | Rutgers, The State University Of New Jersey | Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof |
-
2019
- 2019-05-01 WO PCT/US2019/030198 patent/WO2019213257A1/en not_active Ceased
- 2019-05-01 CA CA3098137A patent/CA3098137A1/en active Pending
- 2019-05-01 JP JP2020560827A patent/JP7506405B2/ja active Active
- 2019-05-01 US US17/051,296 patent/US12398182B2/en active Active
- 2019-05-01 EP EP19727544.9A patent/EP3788155A1/en active Pending
- 2019-05-01 AU AU2019262029A patent/AU2019262029B2/en active Active
-
2024
- 2024-06-07 JP JP2024093050A patent/JP7832700B2/ja active Active
-
2025
- 2025-07-15 US US19/270,184 patent/US20250340600A1/en active Pending
-
2026
- 2026-02-18 AU AU2026201197A patent/AU2026201197A1/en active Pending
- 2026-02-27 JP JP2026031877A patent/JP2026083211A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102455623B1 (ko) | CRISPR/Cas12f1 시스템 효율화를 위한 엔지니어링 된 가이드 RNA 및 그 용도 | |
| US11479775B2 (en) | RNA targeting of mutations via suppressor tRNAs and deaminases | |
| CN113631708B (zh) | 编辑rna的方法和组合物 | |
| JP7680351B2 (ja) | ゲノムを調節するための方法及び組成物 | |
| JP2025028917A (ja) | 核酸構築物及び使用方法 | |
| JP2024099582A (ja) | アルブミン遺伝子座からの導入遺伝子発現のための組成物及び方法 | |
| US20260009027A1 (en) | Prime editing-mediated readthrough of premature termination codons (pert) | |
| KR102900462B1 (ko) | CRISPR/Cas12f1 시스템 효율화를 위한 U-rich tail을 포함하는 엔지니어링 된 가이드 RNA 및 그 용도 | |
| GB2556648A (en) | Methods | |
| CN116949012B (zh) | 一种融合蛋白及其应用 | |
| KR20200135225A (ko) | 단일염기 치환 단백질 및 이를 포함하는 조성물 | |
| KR20230007218A (ko) | 초소형 염기교정 시스템 및 이의 용도 | |
| WO2024251229A1 (zh) | Cas酶及其系统和应用 | |
| CA3256516A1 (en) | Compositions and methods for modulating a genome in T lymphocytes, induced pluripotent stem cells, and respiratory epithelial cells | |
| KR102151064B1 (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 | |
| JP2023550381A5 (cg-RX-API-DMAC7.html) | ||
| JP2023550381A (ja) | 真核生物遺伝子編集のためのベクター、システムおよび方法 | |
| KR20250012711A (ko) | CRISPR/Cas12f1 시스템 효율화를 위한 엔지니어링 된 가이드 RNA 및 그 용도 | |
| JP2025510574A5 (cg-RX-API-DMAC7.html) | ||
| CN114395585B (zh) | 用于碱基编辑的组合物 | |
| JP2025510574A (ja) | 真核生物遺伝子編集のための組成物、システムおよび方法 | |
| WO2026067648A1 (en) | Type ii cas protein and uses thereof | |
| WO2025190256A1 (en) | Type ii cas protein and uses thereof | |
| US20230279398A1 (en) | Treating human t-cell leukemia virus by gene editing | |
| WO2025049792A1 (en) | Compositions and methods for epigenetic regulation of tgfbr2 expression |